- Home
- MMA vs CARM Comparison
MMA vs CARM Comparison
Compare MMA & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- CARM
- Stock Information
- Founded
- MMA 2013
- CARM 2016
- Country
- MMA Australia
- CARM United States
- Employees
- MMA N/A
- CARM N/A
- Industry
- MMA
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- CARM Health Care
- Exchange
- MMA Nasdaq
- CARM Nasdaq
- Market Cap
- MMA 16.3M
- CARM 16.4M
- IPO Year
- MMA 2024
- CARM N/A
- Fundamental
- Price
- MMA $1.33
- CARM $0.40
- Analyst Decision
- MMA
- CARM Hold
- Analyst Count
- MMA 0
- CARM 5
- Target Price
- MMA N/A
- CARM $0.90
- AVG Volume (30 Days)
- MMA 757.5K
- CARM 3.2M
- Earning Date
- MMA 01-21-2025
- CARM 08-07-2025
- Dividend Yield
- MMA N/A
- CARM N/A
- EPS Growth
- MMA N/A
- CARM N/A
- EPS
- MMA N/A
- CARM N/A
- Revenue
- MMA $407,412.00
- CARM $19,964,000.00
- Revenue This Year
- MMA N/A
- CARM N/A
- Revenue Next Year
- MMA N/A
- CARM N/A
- P/E Ratio
- MMA N/A
- CARM N/A
- Revenue Growth
- MMA N/A
- CARM 32.45
- 52 Week Low
- MMA $0.60
- CARM $0.14
- 52 Week High
- MMA $4.11
- CARM $1.38
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- CARM 51.42
- Support Level
- MMA N/A
- CARM $0.38
- Resistance Level
- MMA N/A
- CARM $0.42
- Average True Range (ATR)
- MMA 0.00
- CARM 0.03
- MACD
- MMA 0.00
- CARM -0.01
- Stochastic Oscillator
- MMA 0.00
- CARM 27.93
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.